BRISTOL MYERS SQUIBB (BMY)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for BMY
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| BMY | Director; Board Chair and Chief Executive Officer | [] | [] | 2026 |
Biography sourced from the proxy statement filing.
As our Chief Executive Officer, with more than a decade working in various roles at the Company, Dr. Boerner has proven himself to be an exceptional leader and has been instrumental in shaping our strategy and our culture. His passion for science, his commitment to our workforce and his tireless focus on what matters most our patients make him an invaluable asset to the Company and our Board. Further, his deep knowledge of our strategy and pipeline, and proven execution across all geographies, makes us confident that he is the right person to guide BMS through its next stage of growth and support our vision to be the world s leading biopharma company that transforms patients lives through science.